Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (415)
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
40
Price
$333.23
Total Value
$13.33K
Shares Held After
50,000
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
3,095
Price
$331.43
Total Value
$1.03M
Shares Held After
50,040
% of Holdings
5.8%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
4,896
Price
$330.36
Total Value
$1.62M
Shares Held After
53,135
% of Holdings
8.4%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
7,428
Price
$329.60
Total Value
$2.45M
Shares Held After
58,031
% of Holdings
11.3%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
1,687
Price
$328.52
Total Value
$554.21K
Shares Held After
65,459
% of Holdings
2.5%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
5,226
Price
$327.39
Total Value
$1.71M
Shares Held After
67,146
% of Holdings
7.2%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
2,287
Price
$326.60
Total Value
$746.94K
Shares Held After
72,372
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
ROSSI DINO A — Director
Shares
341
Price
$325.60
Total Value
$111.03K
Shares Held After
74,659
% of Holdings
0.5%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,847
Price
$111.14
Total Value
$427.55K
Shares Held After
31,034
% of Holdings
11.0%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
9,193
Price
$110.00
Total Value
$1.01M
Shares Held After
34,881
% of Holdings
20.9%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,200
Price
$109.11
Total Value
$1.11M
Shares Held After
44,074
% of Holdings
18.8%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
14,696
Price
$107.97
Total Value
$1.59M
Shares Held After
54,274
% of Holdings
21.3%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
10,434
Price
$107.14
Total Value
$1.12M
Shares Held After
68,970
% of Holdings
13.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
3,630
Price
$106.05
Total Value
$384.96K
Shares Held After
79,404
% of Holdings
4.4%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
10,460
Price
$29.48
Total Value
$308.36K
Shares Held After
705,995
% of Holdings
1.5%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
2,375
Price
$28.11
Total Value
$66.76K
Shares Held After
716,455
% of Holdings
0.3%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
5,423
Price
$27.19
Total Value
$147.45K
Shares Held After
718,830
% of Holdings
0.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Lee Jennifer Kayden — EVP, Head of North America
Shares
75,834
Price
$117.38
Total Value
$8.90M
Shares Held After
0
% of Holdings
100.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,358
Price
$108.46
Total Value
$255.76K
Shares Held After
15,312
% of Holdings
13.3%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,142
Price
$107.71
Total Value
$230.72K
Shares Held After
17,670
% of Holdings
10.8%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
1,268
Price
$106.63
Total Value
$135.20K
Shares Held After
19,812
% of Holdings
6.0%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,132
Price
$105.57
Total Value
$225.08K
Shares Held After
21,080
% of Holdings
9.2%
Oruka Therapeutics, Inc. (ORKA)
Agarwal Arjun — Senior Vice President, Finance
Shares
2,100
Price
$104.67
Total Value
$219.81K
Shares Held After
23,212
% of Holdings
8.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$512.36
Total Value
$122.97K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$511.12
Total Value
$81.78K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.92
Total Value
$101.98K
Shares Held After
324,843
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$508.76
Total Value
$325.61K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$507.14
Total Value
$466.57K
Shares Held After
325,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,679
Price
$506.16
Total Value
$849.84K
Shares Held After
326,603
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
961
Price
$505.18
Total Value
$485.48K
Shares Held After
328,282
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$503.83
Total Value
$80.61K
Shares Held After
329,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$502.93
Total Value
$221.29K
Shares Held After
329,403
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,519
Price
$501.88
Total Value
$762.35K
Shares Held After
329,843
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,328
Price
$500.93
Total Value
$665.24K
Shares Held After
331,362
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,253
Price
$500.08
Total Value
$626.60K
Shares Held After
332,690
% of Holdings
0.4%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,919
Price
$43.41
Total Value
$126.70K
Shares Held After
8,625
% of Holdings
25.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,142
Price
$27.61
Total Value
$445.62K
Shares Held After
0
% of Holdings
100.0%
Vericel Corp (VCEL)
MCLAUGHLIN KEVIN F — Director
Shares
7,000
Price
$44.53
Total Value
$311.71K
Shares Held After
18,300
% of Holdings
27.7%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
5,775
Price
$27.75
Total Value
$160.26K
Shares Held After
724,253
% of Holdings
0.8%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
34,225
Price
$26.99
Total Value
$923.73K
Shares Held After
730,028
% of Holdings
4.5%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
804
Price
$82.64
Total Value
$66.44K
Shares Held After
54,324
% of Holdings
1.5%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
43
Price
$35.00
Total Value
$1.50K
Shares Held After
55,285
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
17,319
Price
$117.47
Total Value
$2.03M
Shares Held After
55,655
% of Holdings
23.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
18,208
Price
$116.49
Total Value
$2.12M
Shares Held After
72,974
% of Holdings
20.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
14,568
Price
$115.43
Total Value
$1.68M
Shares Held After
91,182
% of Holdings
13.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
3,605
Price
$114.70
Total Value
$413.48K
Shares Held After
105,750
% of Holdings
3.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
1,000
Price
$112.86
Total Value
$112.86K
Shares Held After
109,355
% of Holdings
0.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
2,300
Price
$111.80
Total Value
$257.14K
Shares Held After
110,355
% of Holdings
2.0%
Septerna, Inc. (SEPN)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
746,500
Price
$42.50
Total Value
$31.73M
Shares Held After
725,443
% of Holdings
50.7%
Septerna, Inc. (SEPN)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
746,500
Price
$42.50
Total Value
$31.73M
Shares Held After
4,777,415
% of Holdings
13.5%
Showing 1–50 of 415 transactions (page 1 of 9)